Global Migraine Drugs Market Professional Survey Report 2017

Published Date : 2017-12-07

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 116

This report studies Migraine Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AstraZeneca Plc.
Allergan Plc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline Plc
Eli Lilly & Co.
Novartis AG
Merck & Co., Inc.
Valeant Pharmaceutical International, Inc.
Janssen Pharmaceutical Company (Johnson & Johnson)
Endo Pharmaceuticals Inc.
Zosano Pharma Corporation
Alder BioPharmaceuticals Inc.
Avanir Pharmaceuticals, Inc.
Eisai Co., Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral
Injectable
Others

By Application, the market can be split into
Retail Pharmacies
Hospital Pharmacies
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Migraine Drugs Market Professional Survey Report 2017
1 Industry Overview of Migraine Drugs
1.1 Definition and Specifications of Migraine Drugs
1.1.1 Definition of Migraine Drugs
1.1.2 Specifications of Migraine Drugs
1.2 Classification of Migraine Drugs
1.2.1 Oral
1.2.2 Injectable
1.2.3 Others
1.3 Applications of Migraine Drugs
1.3.1 Retail Pharmacies
1.3.2 Hospital Pharmacies
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Migraine Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Migraine Drugs
2.3 Manufacturing Process Analysis of Migraine Drugs
2.4 Industry Chain Structure of Migraine Drugs

3 Technical Data and Manufacturing Plants Analysis of Migraine Drugs
3.1 Capacity and Commercial Production Date of Global Migraine Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Migraine Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Migraine Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Migraine Drugs Major Manufacturers in 2016

4 Global Migraine Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Migraine Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Migraine Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Migraine Drugs Sales and Growth Rate Analysis
4.3.2 2016 Migraine Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Migraine Drugs Sales Price
4.4.2 2016 Migraine Drugs Sales Price Analysis (Company Segment)

5 Migraine Drugs Regional Market Analysis
5.1 North America Migraine Drugs Market Analysis
5.1.1 North America Migraine Drugs Market Overview
5.1.2 North America 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Migraine Drugs Sales Price Analysis
5.1.4 North America 2016 Migraine Drugs Market Share Analysis
5.2 China Migraine Drugs Market Analysis
5.2.1 China Migraine Drugs Market Overview
5.2.2 China 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Migraine Drugs Sales Price Analysis
5.2.4 China 2016 Migraine Drugs Market Share Analysis
5.3 Europe Migraine Drugs Market Analysis
5.3.1 Europe Migraine Drugs Market Overview
5.3.2 Europe 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Migraine Drugs Sales Price Analysis
5.3.4 Europe 2016 Migraine Drugs Market Share Analysis
5.4 Southeast Asia Migraine Drugs Market Analysis
5.4.1 Southeast Asia Migraine Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Migraine Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Migraine Drugs Market Share Analysis
5.5 Japan Migraine Drugs Market Analysis
5.5.1 Japan Migraine Drugs Market Overview
5.5.2 Japan 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Migraine Drugs Sales Price Analysis
5.5.4 Japan 2016 Migraine Drugs Market Share Analysis
5.6 India Migraine Drugs Market Analysis
5.6.1 India Migraine Drugs Market Overview
5.6.2 India 2012-2017E Migraine Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Migraine Drugs Sales Price Analysis
5.6.4 India 2016 Migraine Drugs Market Share Analysis

6 Global 2012-2017E Migraine Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Migraine Drugs Sales by Type
6.2 Different Types of Migraine Drugs Product Interview Price Analysis
6.3 Different Types of Migraine Drugs Product Driving Factors Analysis
6.3.1 Oral of Migraine Drugs Growth Driving Factor Analysis
6.3.2 Injectable of Migraine Drugs Growth Driving Factor Analysis
6.3.3 Others of Migraine Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Migraine Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Migraine Drugs Consumption by Application
7.2 Different Application of Migraine Drugs Product Interview Price Analysis
7.3 Different Application of Migraine Drugs Product Driving Factors Analysis
7.3.1 Retail Pharmacies of Migraine Drugs Growth Driving Factor Analysis
7.3.2 Hospital Pharmacies of Migraine Drugs Growth Driving Factor Analysis
7.3.3 Others of Migraine Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Migraine Drugs
8.1 AstraZeneca Plc.
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 AstraZeneca Plc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AstraZeneca Plc. 2016 Migraine Drugs Business Region Distribution Analysis
8.2 Allergan Plc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Allergan Plc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Allergan Plc. 2016 Migraine Drugs Business Region Distribution Analysis
8.3 Pfizer, Inc.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Pfizer, Inc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Pfizer, Inc. 2016 Migraine Drugs Business Region Distribution Analysis
8.4 Teva Pharmaceutical Industries Ltd.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Teva Pharmaceutical Industries Ltd. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Teva Pharmaceutical Industries Ltd. 2016 Migraine Drugs Business Region Distribution Analysis
8.5 GlaxoSmithKline Plc
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 GlaxoSmithKline Plc 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 GlaxoSmithKline Plc 2016 Migraine Drugs Business Region Distribution Analysis
8.6 Eli Lilly & Co.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Eli Lilly & Co. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Eli Lilly & Co. 2016 Migraine Drugs Business Region Distribution Analysis
8.7 Novartis AG
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novartis AG 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novartis AG 2016 Migraine Drugs Business Region Distribution Analysis
8.8 Merck & Co., Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Merck & Co., Inc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Merck & Co., Inc. 2016 Migraine Drugs Business Region Distribution Analysis
8.9 Valeant Pharmaceutical International, Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Valeant Pharmaceutical International, Inc. 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Valeant Pharmaceutical International, Inc. 2016 Migraine Drugs Business Region Distribution Analysis
8.10 Janssen Pharmaceutical Company (Johnson & Johnson)
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Janssen Pharmaceutical Company (Johnson & Johnson) 2016 Migraine Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Janssen Pharmaceutical Company (Johnson & Johnson) 2016 Migraine Drugs Business Region Distribution Analysis
8.11 Endo Pharmaceuticals Inc.
8.12 Zosano Pharma Corporation
8.13 Alder BioPharmaceuticals Inc.
8.14 Avanir Pharmaceuticals, Inc.
8.15 Eisai Co., Ltd.

9 Development Trend of Analysis of Migraine Drugs Market
9.1 Global Migraine Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Migraine Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Migraine Drugs Sales Price Forecast
9.2 Migraine Drugs Regional Market Trend
9.2.1 North America 2017-2022 Migraine Drugs Consumption Forecast
9.2.2 China 2017-2022 Migraine Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Migraine Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Migraine Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Migraine Drugs Consumption Forecast
9.2.6 India 2017-2022 Migraine Drugs Consumption Forecast
9.3 Migraine Drugs Market Trend (Product Type)
9.4 Migraine Drugs Market Trend (Application)

10 Migraine Drugs Marketing Type Analysis
10.1 Migraine Drugs Regional Marketing Type Analysis
10.2 Migraine Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Migraine Drugs by Region
10.4 Migraine Drugs Supply Chain Analysis

11 Consumers Analysis of Migraine Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Migraine Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source



List of Tables and Figures
Figure Picture of Migraine Drugs
Table Product Specifications of Migraine Drugs
Table Classification of Migraine Drugs
Figure Global Production Market Share of Migraine Drugs by Type in 2016
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injectable Picture
Table Major Manufacturers of Injectable
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Migraine Drugs
Figure Global Consumption Volume Market Share of Migraine Drugs by Application in 2016
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Major Consumers in Hospital Pharmacies
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Migraine Drugs by Regions
Figure North America Migraine Drugs Market Size (Million USD) (2012-2022)
Figure China Migraine Drugs Market Size (Million USD) (2012-2022)
Figure Europe Migraine Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Migraine Drugs Market Size (Million USD) (2012-2022)
Figure Japan Migraine Drugs Market Size (Million USD) (2012-2022)
Figure India Migraine Drugs Market Size (Million USD) (2012-2022)
Table Migraine Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Migraine Drugs in 2016
Figure Manufacturing Process Analysis of Migraine Drugs
Figure Industry Chain Structure of Migraine Drugs
Table Capacity and Commercial Production Date of Global Migraine Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Migraine Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Migraine Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Migraine Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Migraine Drugs 2012-2017
Figure Global 2012-2017E Migraine Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Migraine Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Migraine Drugs Capacity and Growth Rate
Table 2016 Global Migraine Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Migraine Drugs Sales (K Units) and Growth Rate
Table 2016 Global Migraine Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Migraine Drugs Sales Price (USD/Unit)
Table 2016 Global Migraine Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Migraine Drugs 2012-2017E
Figure North America 2012-2017E Migraine Drugs Sales Price (USD/Unit)
Figure North America 2016 Migraine Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Migraine Drugs 2012-2017E
Figure China 2012-2017E Migraine Drugs Sales Price (USD/Unit)
Figure China 2016 Migraine Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Migraine Drugs 2012-2017E
Figure Europe 2012-2017E Migraine Drugs Sales Price (USD/Unit)
Figure Europe 2016 Migraine Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Migraine Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Migraine Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Migraine Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Migraine Drugs 2012-2017E
Figure Japan 2012-2017E Migraine Drugs Sales Price (USD/Unit)
Figure Japan 2016 Migraine Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Migraine Drugs 2012-2017E
Figure India 2012-2017E Migraine Drugs Sales Price (USD/Unit)
Figure India 2016 Migraine Drugs Sales Market Share
Table Global 2012-2017E Migraine Drugs Sales (K Units) by Type
Table Different Types Migraine Drugs Product Interview Price
Table Global 2012-2017E Migraine Drugs Sales (K Units) by Application
Table Different Application Migraine Drugs Product Interview Price
Table AstraZeneca Plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Plc. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Plc. Migraine Drugs Business Region Distribution
Table Allergan Plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Allergan Plc. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Allergan Plc. Migraine Drugs Business Region Distribution
Table Pfizer, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2015 Pfizer, Inc. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer, Inc. Migraine Drugs Business Region Distribution
Table Teva Pharmaceutical Industries Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Industries Ltd. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Industries Ltd. Migraine Drugs Business Region Distribution
Table GlaxoSmithKline Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Plc Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Plc Migraine Drugs Business Region Distribution
Table Eli Lilly & Co. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly & Co. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly & Co. Migraine Drugs Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis AG Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis AG Migraine Drugs Business Region Distribution
Table Merck & Co., Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co., Inc. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck & Co., Inc. Migraine Drugs Business Region Distribution
Table Valeant Pharmaceutical International, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Valeant Pharmaceutical International, Inc. Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Valeant Pharmaceutical International, Inc. Migraine Drugs Business Region Distribution
Table Janssen Pharmaceutical Company (Johnson & Johnson) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Business Region Distribution
Table Endo Pharmaceuticals Inc. Information List
Table Zosano Pharma Corporation Information List
Table Alder BioPharmaceuticals Inc. Information List
Table Avanir Pharmaceuticals, Inc. Information List
Table Eisai Co., Ltd. Information List
Figure Global 2017-2022 Migraine Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Migraine Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Migraine Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Migraine Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Migraine Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Migraine Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Migraine Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Migraine Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Migraine Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Migraine Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Migraine Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Migraine Drugs by Region

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com